我要投票 北京天坛医院在男科医院行业中的票数:7
· 外 推 电 报 ·
2024-11-22 08:32:43 星期五

【北京天坛医院是哪个国家的品牌?】

北京天坛医院是什么牌子?「北京天坛医院」是首都医科大学附属北京天坛医院旗下著名品牌。该品牌发源于北京市,由创始人王院长在1956年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。


首都医科大学附属北京天坛医院始建于1956年8月23日,是一所以神经外科为先导,神经科学为特色,集医、教、研、防为一体的三级甲等综合性医院。是世界三大神经外科研究中心之一、亚洲的神经外科临床、科研、教学基地。医院总占地面积83900.56平方米,建筑面积 92898.56平方米,编制床位950张,临床、医技科室45个,全院职工总数2787人。年门急诊量约140余万人次,年住院病人约3万人次,年手术量2万余例次。

北京市神经外科研究所、国家神经系统疾病临床医学研究中心、北京市伽玛刀治疗研究中心、北京市脑血管病抢救治疗中心、国家脑血管病创新药物临床评价技术平台、WHO在中国的神经科学培训合作中心、北京脑重大疾病研究院脑卒中研究所、北京脑重大疾病研究院脑肿瘤研究所、北京神外学院、首都医科大学第五临床医学院、全国脑血管病防治办公室、北京市脑血管病临床研究中心、北京市脑血管病防治指导办公室、中国卒中培训项目以及《中华神经外科杂志》、《中国卒中杂志》等一批机构设在我院。

功能神经外科和清华大学联合被授予神经调控工程中心称号;我院的脑血管病中心是北京市脑血管病临床研究中心和国家“十二五”重大新药创制脑血管病临床评价的依托平台;赵继宗教授获得了“2012年Walter E. Dandy神经外科学会荣誉奖”;戴建平教授入选美国科学院2012年新一批外籍院士,成为继巴德年、陈竺、韩启德之后又一来自中国的该院外籍院士;王拥军副院长获得 2012年首都危险疾病科技成果推广专项和北京市科技惠民奖,主编了2012 年卫生部颁布的《缺血性脑卒中诊断和诊疗质量控制》。

2013年12月19日赵继宗教授当选为中国科学院院士。

我院作为北京市医改第三批试点医院,实施了医药分开试点工作,深入推动了医院管理体制机制变革。开展电子病历、临床路径、DRGs付费、缩短平均住院日、抗菌药物监管治理、加强危急值的管理、处方点评、加强床位管理、优质护理服务等方面的工作。

我院承担了西藏自治区、新疆维吾尔自治区和内蒙古自治区所辖5所医院,以及东城区和丰台区的五所医院的对口支援任务。

医院全体职工在医院党委和领导班子的带领下,发扬王忠诚院士开拓创新、团结协作、严谨求实、艰苦奋斗、病人优先的精神,推动我国神经科学事业向更高水平发展。以“全心全意为病人服务”为宗旨,推进服务质量和医疗质量管理为核心的医疗管理体系;提升学科和人才队伍建设水平,培养更多热爱医院、有才华的专业和管理年轻人才;继续实施绩效管理,创建以绩效考核为核心的人力资源管理体系;完善各项管理监督机制,创建以成本核算为核心的后勤管理体系;推进新院迁建工作尽早进入建设阶段,推动天坛医院实现新的历史跨越,让天坛品牌永葆辉煌。


英文翻译:Beijing Tiantan Hospital, affiliated to Capital Medical University, was founded on August 23, 1956. It is a third-class comprehensive hospital with neurosurgery as the guide and neuroscience as the feature, integrating medicine, teaching, research and prevention. It is one of the three neurosurgery research centers in the world and the clinical, scientific and teaching base of neurosurgery in Asia. The hospital covers an area of 83900.56 square meters, with a building area of 92898.56 square meters. It has 950 beds, 45 clinical and medical technology departments, and 2787 employees. The annual outpatient and emergency treatment volume is about 1.4 million person times, the annual inpatient volume is about 30000 person times, and the annual operation volume is more than 20000. Beijing neurosurgery Research Institute, National Clinical Medicine Research Center for nervous system diseases, Beijing gamma knife treatment research center, Beijing cerebrovascular disease rescue and treatment center, national cerebrovascular disease innovative drug clinical evaluation technology platform, who China neuroscience training cooperation center, stroke research institute of Beijing Institute of major brain diseases, Beijing major brain disease research center The Institute of brain tumor research, Beijing Shenwai college, the fifth Clinical Medical College of Capital Medical University, the National Office of cerebrovascular disease prevention and control, Beijing clinical research center of cerebrovascular disease, Beijing cerebrovascular disease prevention and control guidance office, China stroke training program, China Journal of Neurosurgery, China stroke journal and other institutions are located in our hospital. Functional neurosurgery and Tsinghua University were jointly awarded the title of neuroregulation Engineering Center; the cerebrovascular disease center of our hospital is the supporting platform for clinical evaluation of Beijing cerebrovascular disease clinical research center and national "12th Five Year Plan" major new drug creation cerebrovascular disease; Professor Zhao Jizong won the "2012 Walter E. dandy neurosurgery society honorary Award"; Professor Dai Jianping was selected into American Science In 2012, a new group of foreign academicians of the Academy became another foreign academician from China after badian, Chen Zhu and Han Qide. Wang Yongjun, vice president of the Academy, won the special promotion project of scientific and technological achievements of dangerous diseases in the capital in 2012 and the Beijing Science and Technology Award for the benefit of the people, and edited the diagnosis and treatment quality control of ischemic stroke issued by the Ministry of health in 2012. On December 19, 2013, Professor Zhao Jizong was elected as an academician of the Chinese Academy of Sciences. As the third batch of pilot hospitals of Beijing medical reform, our hospital has carried out the pilot work of separating medicine and further promoted the reform of hospital management system and mechanism. Carry out the work of electronic medical record, clinical pathway, DRGs payment, shortening the average length of stay, antimicrobial drug supervision and management, strengthening the management of critical value, prescription review, strengthening bed management, quality nursing services, etc. Our hospital has undertaken the counterpart support tasks of five hospitals under the jurisdiction of Tibet Autonomous Region, Xinjiang Uygur Autonomous Region and Inner Mongolia Autonomous Region, as well as five hospitals in Dongcheng District and Fengtai District. Under the leadership of the hospital Party committee and the leading group, all staff of the hospital carry forward the spirit of Academician Wang Zhongli's pioneering innovation, unity and cooperation, rigorous and realistic, hard work and patient priority, and promote the development of neuroscience in China to a higher level. With the purpose of "serving patients wholeheartedly", promote the medical management system with service quality and medical quality management as the core; improve the level of discipline and talent team construction, cultivate more professional and management young talents who love hospitals and have talent; continue to implement performance management, create a human resource management system with performance assessment as the core; improve various management and supervision mechanisms To establish a logistics management system with cost accounting as the core; to promote the relocation of the new hospital to enter the construction stage as early as possible, to promote the Tiantan Hospital to achieve a new historical leap, so that the brand of Tiantan will remain brilliant forever.

本文链接: https://www.waitui.com/brand/5984c1b65.html 联系电话:010-67056565

千城特选小程序码

7×24h 快讯

核聚变产业受青睐,多家公司早已涉足

近期,国务院国资委在署名文章中提出超前布局梯次培育量子科技、核聚变、生物制造、6G等未来产业,再次点燃市场对核聚变产业的热情。11月20日,上海未来聚变能源科技有限公司成立,从股东结构来看,其背后有上海电气控股集团有限公司等3家上海国资旗下公司力挺。环顾A股市场,多家上市公司已从产业链不同领域涉足核聚变赛道。昨日,不少投资者在互动平台密集追问旭光电子、合锻智能等上市公司在核聚变领域的技术、产品、项目等最新进展。(上证报)

33分钟前

服装零售商Gap上调全年业绩预期

据报道,服装零售商Gap上调了全年业绩预期,预计本财年销售额将增长1.5%至2%,而此前的预测是增长不到1%,同时上调的还有毛利率和营业收入预测。公司首席执行官理查德·迪克森在接受采访时表示,“从根本上讲,我们的业务比去年要好。”他补充说,该公司的品牌正在“跨类别”抢占市场份额。(界面)

33分钟前

“谈生意不再藏着掖着”,期现融合推动化工产业链共赢

在化工贸易环节,上游想把价格卖在高位,下游想把价格买在低位,这种情况长期存在。但随着期货工具的引入,贸易商发挥期现综合服务优势,使用基差贸易等新型模式推动产业链从“对立”走向“共赢”。贸易环节实现深度期现融合,是近年来化工产业的一大变化。近年来,受产能投放周期等因素影响,化工品价格波动幅度较大,产业链企业加工利润被显著压缩。这种情况下,头部贸易商运用期货和衍生品工具带动行业合作共赢,在保障产业链供应链安全稳定方面发挥了积极作用。(上证报)

33分钟前

中信建投:低碳环保政策持续完善,全面推进资源循环利用

36氪获悉,中信建投研报称,近期,工信部部长金壮龙发表《进一步全面深化工业和信息化领域改革为推进新型工业化注入强大动力》,提出做强绿色制造业,发展绿色低碳产业,完善绿色环保、新能源装备等发展政策。

33分钟前

临近年底,A股易主暗流涌动

临近岁末,A股控制权交易市场暗流涌动。直观来看,“易主”案例近期密集浮现。据不完全统计,10月以来,已有18家上市公司披露交易性控制权变动事项(剔除国资无偿划转、家族内部划转等)。其中,基本面向下、现金流趋紧的公司占据多数,不少公司或面临“戴帽”或“保壳”的压力。水面之下,此前几近沉寂的壳交易,已有买方在摩拳擦掌。多位投行人士反映,近期来咨询买壳事宜的人明显多了起来。(上证报)

33分钟前

本页详细列出关于黄风湿的品牌信息,含品牌所属公司介绍,黄风湿所处行业的品牌地位及优势。
咨询